| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/15/2008 | US7399324 Three dimensional composite; calcium silicate having xontolite structure with textile glass fibers and borosilicate glass; sustained release of fragrance, insect repellant, fire starting material |
| 07/15/2008 | CA2478980C Pulmonary delivery for levodopa |
| 07/15/2008 | CA2465640C Process for forming amorphous atorvastatin |
| 07/15/2008 | CA2441836C New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kitfor preparation of the liver cancer-treating composition |
| 07/15/2008 | CA2426018C Methods and apparatus for making seamless capsules |
| 07/15/2008 | CA2397942C Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation |
| 07/15/2008 | CA2395530C Calcium formate for use as a phosphorus binder and a dietary supplement |
| 07/15/2008 | CA2391393C Film preparation for biphasic release of pharmacologically active or other substances |
| 07/15/2008 | CA2378892C Preserved pharmaceutical formulations |
| 07/15/2008 | CA2373276C Substrate sections with improved storage stability during their storage in bags, and a method for producing the same |
| 07/15/2008 | CA2371940C Pregelatinized starch in a controlled release formulation |
| 07/15/2008 | CA2362271C Essential fatty acids in the prevention of cardiovascular events |
| 07/15/2008 | CA2361602C Firm hold hair mousse |
| 07/15/2008 | CA2361237C Lyophilisates having improved reconstitutibility |
| 07/15/2008 | CA2355175C Soluble compositions of triphenylethylene antiestrogens |
| 07/15/2008 | CA2349711C A method of producing drug particles |
| 07/15/2008 | CA2334411C Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |
| 07/15/2008 | CA2329902C Methods and apparatus for particle formation |
| 07/15/2008 | CA2298487C A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| 07/15/2008 | CA2283327C Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/15/2008 | CA2282184C Stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20% |
| 07/15/2008 | CA2247848C Nitric oxide donors capable of reducing toxicity from drugs |
| 07/15/2008 | CA2245637C Antipsoriatic nail polish |
| 07/15/2008 | CA2231545C Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 07/15/2008 | CA2215306C Osmotic device with high drug loading and delayed activation of drug delivery |
| 07/15/2008 | CA2213612C Composition for controlling parasites |
| 07/15/2008 | CA2183684C Inoculation of animals with dried, pelleted biological materials |
| 07/15/2008 | CA2160938C Muscle relaxant pharmaceutical compositions |
| 07/15/2008 | CA2142528C Process for the manufacture of a starch hydrolysate of low polymolecularity index, obtention and use of novel starch hydrolysate in peritoneal dialysis |
| 07/10/2008 | WO2008083370A2 Compounds, compostions, kits and methods of use to orally and topically treat acne and other skin conditions by adminstering a 19-nor containing vitamin d analog with or without a reyinoid |
| 07/10/2008 | WO2008083302A2 Use of adenosine deaminase for treating pulmonary disease |
| 07/10/2008 | WO2008083149A1 Transdermal method and patch for corticosteroid administration |
| 07/10/2008 | WO2008083092A2 Polynuclear microcapsules |
| 07/10/2008 | WO2008083034A1 Transdermal vitamin b12 delivery patch |
| 07/10/2008 | WO2008082948A2 Ophthalmic alginate composition related methods of manufacture and methods of use |
| 07/10/2008 | WO2008082810A1 Rapidly dissolving tablets comprising low surface area titanium dioxide |
| 07/10/2008 | WO2008082809A1 Rapidly dissolving tablets comprising low surface area calcium phosphates |
| 07/10/2008 | WO2008082808A1 Rapidly disintegrating low friability tablets comprising calcium carbonate |
| 07/10/2008 | WO2008082721A2 Polymer-stabilized liposomal compositions and methods of use |
| 07/10/2008 | WO2008082563A2 Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents |
| 07/10/2008 | WO2008082507A2 Pharmaceutical compositions and method for treating inflammation in cattle and other animals |
| 07/10/2008 | WO2008082373A2 Pharmaceutical formulations comprising lipase inhibitor |
| 07/10/2008 | WO2008082321A1 Emulsion of perfluoroorganic compounds for medical use and a methods for the preparation and the use thereof |
| 07/10/2008 | WO2008082123A1 Nanoparticle composition for prevention of hair loss and promotion of hair growth |
| 07/10/2008 | WO2008081940A1 Gel composition for treating mycosis |
| 07/10/2008 | WO2008081901A1 Pharmaceutical alkyl gallate composition |
| 07/10/2008 | WO2008081891A1 Orally disintegrating solid preparation |
| 07/10/2008 | WO2008081774A1 Orally disintegrating tablet and bitter-blocking preparation each comprising risperidone |
| 07/10/2008 | WO2008081686A1 Cholesterol derivative, liposome, method for forming liposome and contrast agent for x-ray |
| 07/10/2008 | WO2008081590A1 Medical composition |
| 07/10/2008 | WO2008081268A2 Pharmaceutical compositions of entacapone |
| 07/10/2008 | WO2008081175A2 Method of producing a composition from an oleogel and an aqueous gel and the composition |
| 07/10/2008 | WO2008081023A1 Multicompartment bag for storage of iron preparations |
| 07/10/2008 | WO2008080968A1 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 07/10/2008 | WO2008080809A2 Pharmaceutical composition containing psyllium and senna |
| 07/10/2008 | WO2008080774A1 Rapidly dispersable, particulate film coating agent based on polyvinyl alcohol-polyether graft copolymers |
| 07/10/2008 | WO2008080773A1 Method for producing solid dosage forms containing graft copolymers |
| 07/10/2008 | WO2008080369A1 Steady liposomal composition |
| 07/10/2008 | WO2008080367A1 Liposome formulation and process for preparation thereof |
| 07/10/2008 | WO2008061873A3 Stable powder formulation containing a novel anticholinergic agent |
| 07/10/2008 | WO2008060963A3 Layered pharmaceutical formulations comprising an intermediate rapidly dissolving layer |
| 07/10/2008 | WO2008060734A3 Nanoparticle compositions |
| 07/10/2008 | WO2008059522A3 Herbal gastrointenstinal controlled drug delivery dosage forms including pellets and process for their preparation |
| 07/10/2008 | WO2008056375A3 Pharmaceutical formulations comprising valsartan |
| 07/10/2008 | WO2008056344A3 Method of producing microcapsules |
| 07/10/2008 | WO2008054788A9 Transdermal delivery techniques for drugs, nutraceuticals and other active substances |
| 07/10/2008 | WO2008039358A3 Resin-complex granulation for water-soluble drugs and associated methods |
| 07/10/2008 | WO2008029351A3 A modified release formulation comprising amoxicillin and clavulanate |
| 07/10/2008 | WO2008005742A3 Ibuprofen-containing liquid filled hard capsules |
| 07/10/2008 | WO2008005267A3 Sugar-free storage-stable antihistaminic syrups |
| 07/10/2008 | WO2007120725A3 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive |
| 07/10/2008 | WO2007120500A3 Emulsions and microcapsules with substances having low interfacial tension, methods of making and using thereof |
| 07/10/2008 | WO2007103867A3 Tablet formulations and processes |
| 07/10/2008 | WO2007092823A3 Sialagogue coatings for interproximal devices |
| 07/10/2008 | WO2007066335A3 Methods for affecting liposome composition by ultrasound irradiation |
| 07/10/2008 | WO2006138421A3 Nanoparticulate azelnidipine formulations |
| 07/10/2008 | US20080167388 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 07/10/2008 | US20080167365 Of the ACE inhibitor ramipril by mixing with the ramipril (m)ethyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 07/10/2008 | US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors |
| 07/10/2008 | US20080167358 Methods for Obtaining a Fast Dissolving Imidapril Powder |
| 07/10/2008 | US20080167343 Methods and compositions using cholinesterase inhibitors |
| 07/10/2008 | US20080167280 Enhanced drug delivery in transdermal systems |
| 07/10/2008 | US20080167230 treating asthma by administering a trefoil peptide, the human intestinal trefoil factor (ITF), cyclic peptides |
| 07/10/2008 | US20080166800 Method and medicament for inhibiting the expression of a given gene |
| 07/10/2008 | US20080166417 Method of Relieving or Avoiding Side Effect of Steroid |
| 07/10/2008 | US20080166416 Targeted, efficient release; dosing accuracy, well distributed in intestinal lumen; lipophilic matrix providing bioavailability |
| 07/10/2008 | US20080166414 Delivery particles having surface altering agent; transfection efficiency |
| 07/10/2008 | US20080166413 Topical pharmaceutical formulations and methods of treatment |
| 07/10/2008 | US20080166412 Modulating in vivo and/or in vitro with cerium oxide nanoparticles; safe, low cost; neurodegenerative disorders; tissue regeneration |
| 07/10/2008 | US20080166411 Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles |
| 07/10/2008 | US20080166410 improved odor control; diapers; incontinence pads |
| 07/10/2008 | US20080166409 Shape-retentive hydrogel particle aggregates and their uses |
| 07/10/2008 | US20080166408 Oral Dosage Form Comprising Rosiglitazone |
| 07/10/2008 | US20080166407 Tablets containing non-steroidal anti-inflammatory drug (aspirin), agent for reducing gastric acid secretion (omeprazole), thermoplastic hydrophilic polymer (polyoxyethylene glycol), microparticular excipient (microcrystalline cellulose), and cellulosic enteric coating |
| 07/10/2008 | US20080166406 Rapidly Disintegrating Dosage Form Comprising Magnesium Carbonate Heavy |
| 07/10/2008 | US20080166405 Abuse-resistant oral dosage forms and method of use thereof |
| 07/10/2008 | US20080166404 Bioadhesive drug formulations for oral transmucosal delivery |
| 07/10/2008 | US20080166403 Long circulating liposome |
| 07/10/2008 | US20080166402 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 07/10/2008 | US20080166401 For treatment of inflammatory, ischemic or degenerative disorders |